US5417986A
(en)
*
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
US5762965A
(en)
*
|
1984-03-16 |
1998-06-09 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
US20030161889A1
(en)
*
|
1984-03-16 |
2003-08-28 |
Reid Robert H. |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5444113A
(en)
*
|
1988-08-08 |
1995-08-22 |
Ecopol, Llc |
End use applications of biodegradable polymers
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
ATE133087T1
(de)
*
|
1989-05-04 |
1996-02-15 |
Southern Res Inst |
Einkapselungsverfahren
|
CH679207A5
(pt)
*
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
US5484584A
(en)
*
|
1990-10-02 |
1996-01-16 |
Board Of Regents, The University Of Texas System |
Therapeutic and diagnostic use of modified polymeric microcapsules
|
US5238714A
(en)
*
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
US5102402A
(en)
|
1991-01-04 |
1992-04-07 |
Medtronic, Inc. |
Releasable coatings on balloon catheters
|
US5153002A
(en)
*
|
1991-03-04 |
1992-10-06 |
University Of Montreal |
Biocompatible gradient controlled release implant
|
WO1992019263A1
(en)
|
1991-04-24 |
1992-11-12 |
The United States Of America, As Represented By The Secretary Of The Army |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5470582A
(en)
*
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
US5876452A
(en)
*
|
1992-02-14 |
1999-03-02 |
Board Of Regents, University Of Texas System |
Biodegradable implant
|
US6013853A
(en)
*
|
1992-02-14 |
2000-01-11 |
The University Of Texas System |
Continuous release polymeric implant carrier
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
JPH07507768A
(ja)
*
|
1992-03-12 |
1995-08-31 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
Acth含有マイクロスフェアの制御放出
|
US5510077A
(en)
*
|
1992-03-19 |
1996-04-23 |
Dinh; Thomas Q. |
Method of making an intraluminal stent
|
US5591224A
(en)
*
|
1992-03-19 |
1997-01-07 |
Medtronic, Inc. |
Bioelastomeric stent
|
US5599352A
(en)
*
|
1992-03-19 |
1997-02-04 |
Medtronic, Inc. |
Method of making a drug eluting stent
|
US5571166A
(en)
*
|
1992-03-19 |
1996-11-05 |
Medtronic, Inc. |
Method of making an intraluminal stent
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US5711968A
(en)
*
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
US20030035845A1
(en)
*
|
1992-06-11 |
2003-02-20 |
Zale Stephen E. |
Composition for sustained release of non-aggregated erythropoietin
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
AU4932493A
(en)
*
|
1992-09-25 |
1994-04-26 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
ES2151541T3
(es)
|
1992-12-02 |
2001-01-01 |
Alkermes Inc |
Microesferas que contienen hormona del crecimiento de liberacion prolongada.
|
UA61046C2
(en)
*
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
WO1994021289A1
(en)
*
|
1993-03-22 |
1994-09-29 |
THE UNITED STATES OF AMERICA, as represented by THE SECRERATY OF THE ARMY |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5456917A
(en)
*
|
1993-04-12 |
1995-10-10 |
Cambridge Scientific, Inc. |
Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
KR100354270B1
(ko)
|
1993-11-19 |
2003-02-11 |
알커메스 컨트롤드 테라포이틱스 인코퍼레이티드 Ii |
마이크로캡슐화된3-피페리디닐-치환된1,2-벤즈이속사졸및1,2-벤즈이소티아졸
|
WO1995024929A2
(en)
*
|
1994-03-15 |
1995-09-21 |
Brown University Research Foundation |
Polymeric gene delivery system
|
ATE209907T1
(de)
*
|
1994-04-08 |
2001-12-15 |
Atrix Lab Inc |
Flüssige mittel zur wirkstoffabgabe
|
US5876735A
(en)
*
|
1994-04-22 |
1999-03-02 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6013268A
(en)
|
1994-04-22 |
2000-01-11 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US5583114A
(en)
|
1994-07-27 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Adhesive sealant composition
|
USRE38827E1
(en)
|
1994-07-27 |
2005-10-11 |
3M Innovative Properties Company |
Adhesive sealant composition
|
KR100201352B1
(ko)
*
|
1995-03-16 |
1999-06-15 |
성재갑 |
단일주사 백신 제형
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
AUPN366795A0
(en)
*
|
1995-06-20 |
1995-07-13 |
Peptide Technology Limited |
Formulation for preventing reproductive function
|
WO1997007788A2
(en)
*
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
IL123506A
(en)
|
1995-09-01 |
2004-12-15 |
Corixa Corp |
Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
ATE192334T1
(de)
|
1995-11-09 |
2000-05-15 |
Microbiological Res Authority |
Mikroverkapselte dna zur impfung und gentherapie
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
EP1007080B1
(en)
*
|
1996-08-30 |
2007-04-18 |
Peptech Limited |
Formulation for the sustained release of peptide agonists and analogues of GnRH
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
WO1998035045A2
(en)
|
1997-02-12 |
1998-08-13 |
Corixa Corporation |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
ZA982968B
(en)
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
TW577759B
(en)
*
|
1997-04-18 |
2004-03-01 |
Ipsen Pharma Biotech |
Sustained release compositions in the form of microcapsules or implants and the process for their preparation
|
EP1042360A2
(en)
|
1997-12-24 |
2000-10-11 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
AR020318A1
(es)
|
1998-03-18 |
2002-05-08 |
Corixa Corp |
Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion,
|
WO1999051748A2
(en)
|
1998-04-07 |
1999-10-14 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
WO1999052708A1
(en)
|
1998-04-13 |
1999-10-21 |
Luminex Corporation |
Liquid labeling with fluorescent microparticles
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
KR100293504B1
(ko)
|
1998-06-05 |
2001-07-12 |
김윤 |
서방형전립선염치료제조성물
|
EP1100473A2
(en)
|
1998-07-28 |
2001-05-23 |
InnerDyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
EP1102790B1
(en)
|
1998-08-07 |
2014-05-07 |
University of Washington |
Immunological Herpes Simplex Virus antigens and methods for use thereof
|
US6013122A
(en)
*
|
1998-08-18 |
2000-01-11 |
Option Technologies, Inc. |
Tattoo inks
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
WO2000030592A1
(en)
*
|
1998-11-20 |
2000-06-02 |
The General Hospital Corporation |
Permanent, removable tissue markings
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
AU769293B2
(en)
|
1998-12-08 |
2004-01-22 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
ATE399793T1
(de)
|
1999-04-02 |
2008-07-15 |
Corixa Corp |
Verbindungen und verfahren für therapie und diagnose von lungenkrebs
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
US6306425B1
(en)
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
AU779978B2
(en)
*
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US6682754B2
(en)
*
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US6575888B2
(en)
|
2000-01-25 |
2003-06-10 |
Biosurface Engineering Technologies, Inc. |
Bioabsorbable brachytherapy device
|
EP1257257B1
(en)
|
2000-02-17 |
2018-10-31 |
Neomend, Inc. |
Method for producing delivery systems using preformed biodegradable polymer compositions
|
DK1265915T3
(da)
|
2000-02-23 |
2011-02-14 |
Glaxosmithkline Biolog Sa |
Nye forbindelser
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
DE60133190T2
(de)
|
2000-04-21 |
2009-04-02 |
CORIXA CORP., Wilmington |
Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
|
CA2410052A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Delivery systems for bioactive agents
|
PT1542732E
(pt)
|
2000-06-20 |
2009-11-06 |
Corixa Corp |
Proteínas de fusão de mycobacterium tuberculosis
|
WO2002000174A2
(en)
|
2000-06-28 |
2002-01-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
KR100392501B1
(ko)
*
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
US20040158317A1
(en)
*
|
2000-07-18 |
2004-08-12 |
Pharmasonics, Inc. |
Coated stent with ultrasound therapy
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
ES2326209T3
(es)
|
2000-10-27 |
2009-10-05 |
Baxter Healthcare S.A. |
Produccion de microesferas.
|
US20040122090A1
(en)
*
|
2001-12-07 |
2004-06-24 |
Lipton Stuart A. |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
|
DE60130917T2
(de)
|
2000-12-21 |
2008-07-17 |
Alrise Biosystems Gmbh |
Induziertes phasenübergangsverfahren zur herstellung von hydrophile wirkstoffe enthaltenden mikropartikeln
|
US20030033007A1
(en)
*
|
2000-12-22 |
2003-02-13 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
US7083642B2
(en)
|
2000-12-22 |
2006-08-01 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US7077859B2
(en)
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
US7018405B2
(en)
|
2000-12-22 |
2006-03-28 |
Avantec Vascular Corporation |
Intravascular delivery of methylprednisolone
|
US20050203612A1
(en)
*
|
2000-12-22 |
2005-09-15 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
US6939375B2
(en)
|
2000-12-22 |
2005-09-06 |
Avantac Vascular Corporation |
Apparatus and methods for controlled substance delivery from implanted prostheses
|
US6471980B2
(en)
|
2000-12-22 |
2002-10-29 |
Avantec Vascular Corporation |
Intravascular delivery of mycophenolic acid
|
US20020082678A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Motasim Sirhan |
Intravascular delivery of mizoribine
|
US20020082679A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Avantec Vascular Corporation |
Delivery or therapeutic capable agents
|
US20030050692A1
(en)
*
|
2000-12-22 |
2003-03-13 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
CN101684158A
(zh)
|
2001-01-17 |
2010-03-31 |
特鲁比昂药品公司 |
结合域-免疫球蛋白融合蛋白
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
US7618939B2
(en)
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
US6537195B2
(en)
|
2001-05-07 |
2003-03-25 |
Xoft, Microtube, Inc. |
Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
|
US7041046B2
(en)
*
|
2001-05-07 |
2006-05-09 |
Xoft, Inc. |
Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
JP2004535431A
(ja)
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
CA2452382A1
(en)
|
2001-07-10 |
2003-01-23 |
Corixa Corporation |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
WO2003009777A2
(en)
*
|
2001-07-26 |
2003-02-06 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
US20030064033A1
(en)
*
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
JP4308653B2
(ja)
|
2001-09-13 |
2009-08-05 |
アンセル・ヘルスケア・プロダクツ・エルエルシー |
手袋のマイクロカプセルコーティング
|
ES2516041T3
(es)
|
2001-10-10 |
2014-10-30 |
Ratiopharm Gmbh |
Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH)
|
EP2305311A3
(en)
|
2001-10-10 |
2011-07-20 |
BioGeneriX AG |
Glycoconjugation of peptides
|
NZ555055A
(en)
|
2001-12-11 |
2010-06-25 |
Pasteur Institut |
Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
|
AU2002365279B2
(en)
|
2001-12-17 |
2009-08-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
US20030220297A1
(en)
|
2002-02-01 |
2003-11-27 |
Berstein David L. |
Phosphorus-containing compounds and uses thereof
|
US7026465B2
(en)
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
ES2665999T3
(es)
*
|
2002-05-31 |
2018-04-30 |
Titan Pharmaceuticals, Inc. |
Dispositivo polimérico implantable para la liberación sostenida de buprenorfina
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
ATE494907T1
(de)
|
2002-07-18 |
2011-01-15 |
Univ Washington |
Pharmazeutische zusammensetzungen, die immunologisch aktive herpes simplex virus proteinfragmente enthalten
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
EP3299465A1
(en)
|
2003-03-07 |
2018-03-28 |
DSM IP Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
ES2420581T3
(es)
|
2003-03-14 |
2013-08-26 |
Biogenerix Gmbh |
Polímeros solubles en agua ramificados y sus conjugados
|
PL1610791T3
(pl)
|
2003-03-31 |
2011-07-29 |
Titan Pharmaceuticals Inc |
Wszczepialne urządzenie polimerowe do przedłużonego uwalniania agonisty dopaminy
|
US20040254419A1
(en)
*
|
2003-04-08 |
2004-12-16 |
Xingwu Wang |
Therapeutic assembly
|
US20070010702A1
(en)
*
|
2003-04-08 |
2007-01-11 |
Xingwu Wang |
Medical device with low magnetic susceptibility
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
BRPI0409032A
(pt)
*
|
2003-04-10 |
2006-05-02 |
Pr Pharmaceuticals |
método para a produção de micropartìculas à base de emulsão
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
ES2586401T3
(es)
|
2003-06-16 |
2016-10-14 |
Ucb Pharma S.A. |
Anticuerpos específicos para la esclerostina y métodos para aumentar la mineralización ósea
|
US8871269B2
(en)
*
|
2003-07-15 |
2014-10-28 |
Evonik Corporation |
Method for the preparation of controlled release formulations
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
JP2007531701A
(ja)
*
|
2003-07-18 |
2007-11-08 |
バクスター・インターナショナル・インコーポレイテッド |
制御された相分離により調製される小球状粒子の作製方法、使用および組成物
|
CA2532874A1
(en)
*
|
2003-07-22 |
2005-02-03 |
Baxter International Inc. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
CA2533592C
(en)
*
|
2003-07-23 |
2015-11-10 |
Pr Pharmaceuticals, Inc. |
Controlled release compositions
|
US20070149496A1
(en)
*
|
2003-10-31 |
2007-06-28 |
Jack Tuszynski |
Water-soluble compound
|
WO2005051229A2
(en)
*
|
2003-11-24 |
2005-06-09 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
JP5060134B2
(ja)
|
2003-12-12 |
2012-10-31 |
ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
ヒト細胞傷害性Tリンパ球のエピトープ及びそのMUC−1の非VNTR(non−variablenumberoftandemrepeatsequence)由来のアゴニストエピトープ
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
CA2556753C
(en)
|
2004-02-20 |
2014-11-25 |
Lifescape Biosciences Incorporated |
Compositions and methods for sleep regulation
|
US20070027523A1
(en)
*
|
2004-03-19 |
2007-02-01 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using coated balloon
|
US8431145B2
(en)
|
2004-03-19 |
2013-04-30 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
US20100030183A1
(en)
*
|
2004-03-19 |
2010-02-04 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using a coated balloon
|
WO2005089855A1
(en)
*
|
2004-03-19 |
2005-09-29 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
US20050249667A1
(en)
*
|
2004-03-24 |
2005-11-10 |
Tuszynski Jack A |
Process for treating a biological organism
|
EP2409707B8
(en)
|
2004-04-15 |
2015-05-06 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20050239723A1
(en)
*
|
2004-04-27 |
2005-10-27 |
Amin Avinash N |
Compositions and methods useful for treatment of acne
|
DK1758558T3
(da)
*
|
2004-05-12 |
2014-01-20 |
Baxter Int |
Oligonukleotidholdige mikrokugler samt deres anvendelse til fremstilling af et medikament til behandling af diabetes type 1
|
ES2313350T3
(es)
*
|
2004-05-12 |
2009-03-01 |
Baxter International Inc. |
Microesferas de acido nucleico, produccion y suministro de las mismas.
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
MXPA06012992A
(es)
*
|
2004-05-12 |
2007-02-12 |
Baxter Int |
Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
|
US20080199493A1
(en)
|
2004-05-25 |
2008-08-21 |
Picker Louis J |
Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors
|
US7604978B2
(en)
|
2004-07-14 |
2009-10-20 |
Sequoia Sciences, Inc. |
Inhibition of biofilm formation
|
EP2199801B1
(en)
|
2004-07-14 |
2013-05-29 |
The Regents of The University of California |
Biomarkers for early detection of ovarian cancer
|
US20060014285A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Eldridge Gary R |
Methods and compositions for inhibiting biofilms
|
US20060264411A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Eldridge Gary R |
Control of biofilm formation
|
US9132116B2
(en)
|
2004-08-02 |
2015-09-15 |
Willowcroft Pharm Inc. |
Mast cell stabilizers to prevent or treat laminitis
|
CA2575988C
(en)
*
|
2004-08-04 |
2014-02-18 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
EP1797108A1
(en)
|
2004-09-14 |
2007-06-20 |
Gary R. Eldridge |
Compounds, compositions and methods for controlling biofilms and bacterial infections
|
EP2808384B1
(en)
|
2004-10-08 |
2017-12-06 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
US7619007B2
(en)
*
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
JP2008520736A
(ja)
|
2004-11-23 |
2008-06-19 |
アマダス ファーマシューティカルズ インコーポレイテッド |
持続放出コーティングまたはマトリックスおよびnmda受容体アンタゴニストを含む組成物、そのようなnmdaアンタゴニストの被験体への投与方法
|
EP2623099A1
(en)
|
2004-11-24 |
2013-08-07 |
Neuromolecular Pharmaceuticals, Inc |
Composition and method for treating neurological disease
|
US20070150051A1
(en)
*
|
2005-01-10 |
2007-06-28 |
Duke Fiduciary, Llc |
Vascular implants and methods of fabricating the same
|
US8287583B2
(en)
*
|
2005-01-10 |
2012-10-16 |
Taheri Laduca Llc |
Apparatus and method for deploying an implantable device within the body
|
US9029331B2
(en)
|
2005-01-10 |
2015-05-12 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US9050393B2
(en)
*
|
2005-02-08 |
2015-06-09 |
Bruce N. Saffran |
Medical devices and methods for modulation of physiology using device-based surface chemistry
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
KR20070121814A
(ko)
|
2005-03-31 |
2007-12-27 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
클라미디아 감염에 대비한 백신
|
US20060228384A1
(en)
*
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
KR101406456B1
(ko)
*
|
2005-04-06 |
2014-06-20 |
아다마스 파마슈티칼스, 인코포레이티드 |
Cns 장애의 치료를 위한 방법 및 조성물
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
AU2006241145B2
(en)
*
|
2005-04-27 |
2011-04-28 |
Baxter Healthcare S. A. |
Surface-modified microparticles and methods of forming and using the same
|
EP2457926B1
(en)
|
2005-04-29 |
2014-09-24 |
GlaxoSmithKline Biologicals S.A. |
Novel method for preventing or treating M. tuberculosis infection
|
EP1910410B1
(en)
|
2005-07-01 |
2011-10-26 |
Forsyth Dental Infirmary for Children |
Tuberculosis antigen detection assays and vaccines
|
KR100741867B1
(ko)
*
|
2005-07-05 |
2007-07-24 |
전북대학교산학협력단 |
수중유적 및 용매 증발법을 이용한 이중층 미립구의제조방법
|
US20070014739A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Eldridge Gary R |
Compositions and methods for controlling biofilms and bacterial infections
|
JP4997239B2
(ja)
*
|
2005-07-22 |
2012-08-08 |
ワイズ・エー・シー株式会社 |
抗cd26抗体およびその使用方法
|
ES2460517T3
(es)
|
2005-07-25 |
2014-05-13 |
Emergent Product Development Seattle, Llc |
Reducción de células b mediante el uso de moléculas de unión específica a cd37 y de unión específica a cd20
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US20070191272A1
(en)
*
|
2005-09-27 |
2007-08-16 |
Stemmer Willem P |
Proteinaceous pharmaceuticals and uses thereof
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
BRPI0620063B8
(pt)
*
|
2005-12-22 |
2021-05-25 |
Novartis Ag |
composição farmacêutica de liberação sustentada na forma de micropartículas, uso, e kit de administração
|
US20070190127A1
(en)
|
2005-12-30 |
2007-08-16 |
Mingdong Zhou |
Extended release of neuregulin for improved cardiac function
|
US8859209B2
(en)
*
|
2006-01-12 |
2014-10-14 |
Carviar Aps |
Reimmunization and antibody design
|
EP1981905B1
(en)
|
2006-01-16 |
2016-08-31 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Chlamydia vaccine
|
WO2007092314A2
(en)
|
2006-02-02 |
2007-08-16 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
US8921050B2
(en)
|
2006-03-17 |
2014-12-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of diagnosing renal cell carcinoma
|
JP5524610B2
(ja)
|
2006-04-07 |
2014-06-18 |
ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク |
トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
|
US8859233B2
(en)
*
|
2006-05-02 |
2014-10-14 |
Carviar Aps |
Method for immunizing an avian species
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
KR101571027B1
(ko)
|
2006-06-12 |
2015-11-23 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
효과기 기능을 갖는 단일쇄 다가 결합 단백질
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
AU2007281737B2
(en)
|
2006-08-04 |
2013-09-19 |
Baxter Healthcare S.A. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
US20090181078A1
(en)
*
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
LT2484375T
(lt)
|
2006-09-26 |
2018-07-10 |
Infectious Disease Research Institute |
Vakcinos kompozicija, turinti sintetinio adjuvanto
|
SI2068907T1
(en)
|
2006-10-04 |
2018-01-31 |
Novo Nordisk A/S |
Pegylated sugars and glycopeptides are associated with glycerol
|
WO2008060786A2
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
EP2114303A4
(en)
|
2007-02-09 |
2012-08-08 |
Taheri Laduca Llc |
VASCULAR IMPLANTS AND METHODS OF MAKING SAID IMPLANTS
|
AU2008242842B2
(en)
*
|
2007-04-17 |
2014-06-05 |
Baxter Healthcare Sa |
Nucleic acid microparticles for pulmonary delivery
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
PT2500014T
(pt)
*
|
2007-06-06 |
2018-11-21 |
Debiopharm Int Sa |
Composição farmacêutica de libertação prolongada constituída por micropartículas
|
AU2008287195A1
(en)
*
|
2007-07-06 |
2009-02-19 |
Emergent Product Development Seattle, Llc |
Binding peptides having a C-terminally disposed specific binding domain
|
KR20100058541A
(ko)
*
|
2007-08-15 |
2010-06-03 |
아뮤닉스 인코포레이티드 |
생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
|
JP2010540618A
(ja)
*
|
2007-10-02 |
2010-12-24 |
アリエル−ユニバーシティー リサーチ アンド デベロップメント カンパニー リミテッド |
幼児の成長および発達を増大するための内在性カンナビノイド
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
US7828840B2
(en)
*
|
2007-11-15 |
2010-11-09 |
Med Institute, Inc. |
Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
|
EP2222284B1
(en)
*
|
2007-11-19 |
2020-07-01 |
Capsulated Systems Inc. |
Prolonged release of local anesthetics using microparticles and surgery applications
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
ES2718612T3
(es)
|
2007-12-20 |
2019-07-03 |
Evonik Corp |
Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US10000568B2
(en)
|
2008-04-10 |
2018-06-19 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR in cancer
|
CN102099377A
(zh)
*
|
2008-04-11 |
2011-06-15 |
新兴产品开发西雅图有限公司 |
Cd37免疫治疗剂及其与双功能化学治疗剂的联合
|
WO2009129544A1
(en)
|
2008-04-18 |
2009-10-22 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
EP2123748A1
(en)
|
2008-05-20 |
2009-11-25 |
Institut Pasteur |
2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
|
US8765162B2
(en)
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
ES2589915T3
(es)
|
2008-10-08 |
2016-11-17 |
Xgene Pharmaceutical Inc |
Conjugados de GABA y métodos de utilización de los mismos
|
JP2012515791A
(ja)
*
|
2009-01-23 |
2012-07-12 |
サーモディクス ファーマシューティカルズ, インコーポレイテッド |
ポリマー混成物由来の放出制御システム
|
US20100216948A1
(en)
*
|
2009-01-23 |
2010-08-26 |
Tipton Arthur J |
Polymer mixtures comprising polymers having different non-repeating units and methods for making and using same
|
ES2730800T3
(es)
*
|
2009-02-03 |
2019-11-12 |
Amunix Pharmaceuticals Inc |
Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
|
PT2418945T
(pt)
|
2009-04-15 |
2019-03-04 |
Bmg Pharma S P A |
Composições de sal mineral-ácido sulfónico e métodos de utilização
|
BRPI1011072B1
(pt)
|
2009-06-05 |
2021-09-28 |
Infectious Disease Research Institute |
Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
US8911766B2
(en)
*
|
2009-06-26 |
2014-12-16 |
Abbott Cardiovascular Systems Inc. |
Drug delivery compositions including nanoshells for triggered drug release
|
EP2292260A1
(en)
|
2009-08-13 |
2011-03-09 |
Institut Pasteur |
Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
|
AU2010290131C1
(en)
|
2009-08-24 |
2015-12-03 |
Amunix Operating Inc. |
Coagulation factor VII compositions and methods of making and using same
|
EP2477652B1
(en)
|
2009-09-16 |
2015-04-15 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
RU2012115120A
(ru)
*
|
2009-09-17 |
2013-10-27 |
Евоник Дегусса Корпорейшн |
Имплантируемые устройства, которые отличаются профилем высвобождения, и способы их изготовления и применения
|
CA2775077C
(en)
*
|
2009-09-22 |
2018-05-01 |
Evonik Degussa Corporation |
Implant devices having varying bioactive agent loading configurations
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
CN102781259A
(zh)
|
2009-09-30 |
2012-11-14 |
加利福尼亚大学董事会 |
辅因子及个体使用方法
|
AU2010313456A1
(en)
|
2009-10-30 |
2012-05-17 |
Ntf Therapeutics, Inc. |
Improved neurturin molecules
|
US20110104138A1
(en)
|
2009-11-03 |
2011-05-05 |
Institut Pasteur |
Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
|
US9321999B2
(en)
|
2009-11-19 |
2016-04-26 |
Solis Biodyne Oü |
Compositions for increasing polypeptide stability and activity, and related methods
|
BR112012013487A2
(pt)
|
2009-12-02 |
2017-10-03 |
Adamas Pharmaceuticals Inc |
Composições de amantadina e métodos de uso
|
US8951595B2
(en)
*
|
2009-12-11 |
2015-02-10 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable molecular architecture for drug-coated balloon
|
US20110144577A1
(en)
*
|
2009-12-11 |
2011-06-16 |
John Stankus |
Hydrophilic coatings with tunable composition for drug coated balloon
|
US8480620B2
(en)
*
|
2009-12-11 |
2013-07-09 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable solubility profile for drug-coated balloon
|
EP2523956A1
(en)
|
2010-01-13 |
2012-11-21 |
Institut Pasteur Korea |
Anti - infective pyrido (1,2 -a) pyrimidines
|
EA201290590A1
(ru)
|
2010-01-27 |
2013-03-29 |
Глаксосмитклайн Байолоджикалс С.А. |
Модифицированные туберкулезные антигены
|
WO2011116396A2
(en)
|
2010-03-19 |
2011-09-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
|
US9295663B2
(en)
|
2010-07-14 |
2016-03-29 |
Abbott Cardiovascular Systems Inc. |
Drug coated balloon with in-situ formed drug containing microspheres
|
EP2601609B1
(en)
|
2010-08-02 |
2017-05-17 |
Population Bio, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
EP2643045A4
(en)
|
2010-11-23 |
2016-01-13 |
Presage Biosciences Inc |
THERAPEUTIC PROCESSES AND COMPOSITIONS FOR SOLID FORM DELIVERY
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012225390B2
(en)
|
2011-03-08 |
2015-11-12 |
Sagimet Biosciences Inc. |
Heterocyclic modulators of lipid synthesis
|
EP2683736B1
(en)
|
2011-03-09 |
2018-01-17 |
Cell Signaling Technology, Inc. |
Methods and reagents for creating monoclonal antibodies
|
MX350795B
(es)
|
2011-04-08 |
2017-09-19 |
Inmune Design Corp |
Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
|
WO2012174455A2
(en)
|
2011-06-17 |
2012-12-20 |
University Of Tennessee Research Foundation |
Group a streptococcus multivalent vaccine
|
MX2013013627A
(es)
|
2011-06-21 |
2014-04-25 |
Oncofactor Corp |
Composiciones y metodos para la terapia y diagnostico de cancer.
|
US8623924B2
(en)
|
2011-07-15 |
2014-01-07 |
Nusirt Sciences, Inc. |
Compositions and methods for modulating metabolic pathways
|
US8324264B1
(en)
|
2011-07-22 |
2012-12-04 |
Sequoia Sciences, Inc. |
Inhibitors of bacterial biofilms and related methods
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
CN104023760A
(zh)
|
2011-10-28 |
2014-09-03 |
普莱萨格生命科学公司 |
药物递送方法
|
US11180807B2
(en)
|
2011-11-04 |
2021-11-23 |
Population Bio, Inc. |
Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
|
EP2776451B1
(en)
|
2011-11-11 |
2018-07-18 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
CA2863887C
(en)
|
2012-02-09 |
2023-01-03 |
Population Diagnostics, Inc. |
Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos)
|
CA2864126A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
SI3564260T1
(sl)
|
2012-02-15 |
2023-02-28 |
Bioverativ Therapeutics Inc. |
Sestavki faktorja VIII in postopki njegove izdelave in uporabe
|
CN104780932A
(zh)
|
2012-02-29 |
2015-07-15 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
WO2013134577A2
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen, Inc. |
Leishmaniasis antigen detection assays and vaccines
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
PL2850431T3
(pl)
|
2012-05-16 |
2018-09-28 |
Immune Design Corp. |
Szczepionki przeciwko HSV-2
|
EP2895621B1
(en)
|
2012-09-14 |
2020-10-21 |
Population Bio, Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
EP2900835A4
(en)
|
2012-09-27 |
2016-05-11 |
Population Diagnotics Inc |
METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DEVELOPMENTAL DISORDERS
|
AU2013344753B2
(en)
|
2012-11-13 |
2018-09-27 |
Nusirt Sciences, Inc. |
Compositions and methods for increasing energy metabolism
|
US20150359771A1
(en)
|
2013-01-15 |
2015-12-17 |
Nusirt Sciences, Inc. |
Treating pulmonary conditions
|
CA2902879C
(en)
|
2013-03-15 |
2023-09-26 |
Nusirt Sciences, Inc. |
Leucine and nicotinic acid reduces lipid levels
|
BR112015025709A2
(pt)
|
2013-04-18 |
2017-07-18 |
Immune Design Corp |
monoterapia com gla para uso em tratamento de câncer
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
US10231993B2
(en)
|
2013-06-27 |
2019-03-19 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
CN105407728A
(zh)
|
2013-07-21 |
2016-03-16 |
霍勒拜欧姆公司 |
用于微生物组表征、监测和治疗的方法和系统
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
EP3083583B1
(en)
|
2013-12-20 |
2020-11-18 |
Sagimet Biosciences Inc. |
Heterocyclic modulators of lipid synthesis and combinations thereof
|
BR112016015879B1
(pt)
|
2014-01-07 |
2022-06-14 |
Sagimet Biosciences Inc |
Composto modulador heterocíclico de síntese de lipídeos, composição farmacêutica que compreende dito composto e uso do mesmo para o tratamento de câncer
|
CA2935722A1
(en)
|
2014-01-21 |
2015-07-30 |
Immune Design Corp. |
Compositions for use in the treatment of allergic conditions
|
KR102396817B1
(ko)
|
2014-02-20 |
2022-05-11 |
박사르트, 인크. |
소장 전달을 위한 제형들
|
SG11201607075TA
(en)
|
2014-02-27 |
2016-09-29 |
Nusirt Sciences Inc |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
US10590433B2
(en)
|
2014-03-14 |
2020-03-17 |
University Of Washington |
Genomic insulator elements and uses thereof
|
WO2015149016A2
(en)
|
2014-03-28 |
2015-10-01 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
WO2016011386A1
(en)
|
2014-07-18 |
2016-01-21 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
US10724096B2
(en)
|
2014-09-05 |
2020-07-28 |
Population Bio, Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
CA2964467A1
(en)
|
2014-10-14 |
2016-04-21 |
Research Development Foundation |
Methods for generating engineered enzymes
|
EP3212001A4
(en)
|
2014-10-31 |
2018-04-25 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
CA2979696A1
(en)
|
2015-03-19 |
2016-09-22 |
3-V Biosciences, Inc. |
Heterocyclic modulators of lipid synthesis
|
EP3791859A1
(en)
|
2015-06-12 |
2021-03-17 |
Vaxart, Inc. |
Formulations for small intestinal delivery of rsv and norovirus antigens
|
CN108472337B
(zh)
|
2015-08-03 |
2022-11-25 |
比奥贝拉蒂治疗公司 |
因子ix融合蛋白以及其制备和使用方法
|
CA2999138C
(en)
|
2015-09-21 |
2024-05-21 |
Aptevo Research And Development Llc |
Cd3 binding polypeptides
|
EP3383418B1
(en)
|
2015-12-04 |
2021-10-20 |
Board of Regents, The University of Texas System |
Slc45a2 peptides for immunotherapy
|
JP6902033B2
(ja)
|
2015-12-30 |
2021-07-14 |
アダマス ファーマシューティカルズ, インコーポレイテッド |
発作−関連障害の処置のための方法および組成物
|
US10845367B2
(en)
|
2016-05-04 |
2020-11-24 |
Abilita Bio, Inc. |
Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
|
EP4112638A1
(en)
|
2016-05-16 |
2023-01-04 |
Access to Advanced Health Institute |
Formulation containing tlr agonist and methods of use
|
WO2017200957A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
SG11201810102SA
(en)
|
2016-05-16 |
2018-12-28 |
Intarcia Therapeutics Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
EP3463300A1
(en)
|
2016-06-01 |
2019-04-10 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
EP3589243A1
(en)
|
2017-02-28 |
2020-01-08 |
University College Cork - National University of Ireland, Cork |
An intravascular cell therapy device
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
CA3066915A1
(en)
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
EP3638207A1
(en)
|
2017-06-15 |
2020-04-22 |
Infectious Disease Research Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
CN111372596A
(zh)
|
2017-08-30 |
2020-07-03 |
潘德勒姆治疗公司 |
用于治疗微生物组相关病症的方法和组合物
|
CN110123789A
(zh)
*
|
2018-02-02 |
2019-08-16 |
山东墨海生物科技有限公司 |
一种载利培酮的plga微球混合物及其制备方法
|
AU2019217207A1
(en)
|
2018-02-12 |
2020-08-27 |
Diabetes-Free, Inc. |
Improved antagonistic anti-human CD40 monoclonal antibodies
|
WO2020001657A1
(en)
|
2018-06-29 |
2020-01-02 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
SG11202012044QA
(en)
|
2018-06-29 |
2021-01-28 |
Wuhan Neurophth Biological Tech Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
SI3625368T1
(sl)
|
2018-08-08 |
2023-04-28 |
Pml Screening, Llc |
Postopki z genetskim testiranjem za oceno tveganja za razvoj progresivne multifokalne levkoencefalopatije, ki jo povzroča virus John Cunningham
|
AU2019323434A1
(en)
|
2018-08-20 |
2021-02-25 |
Wuhan Neurophth Biotechnology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
WO2020051766A1
(zh)
|
2018-09-11 |
2020-03-19 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
WO2020067887A1
(en)
|
2018-09-24 |
2020-04-02 |
Erasmus University Medical Center Rotterdam |
Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
|
WO2020102454A1
(en)
|
2018-11-13 |
2020-05-22 |
Regents Of The University Of Minnesota |
Cd40 targeted peptides and uses thereof
|
US20210047425A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
CN113025633A
(zh)
|
2019-12-09 |
2021-06-25 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
US20230212256A1
(en)
|
2020-05-21 |
2023-07-06 |
Board Of Regents, The University Of Texas System |
T cell receptors with vgll1 specificity and uses thereof
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
US20230338501A1
(en)
|
2020-09-04 |
2023-10-26 |
Access To Advanced Health Institute |
Live-attenuated rna hybrid vaccine technology
|
CA3174411A1
(en)
|
2020-09-04 |
2022-03-10 |
Ryan M. Kramer |
Co-lyophilized rna and nanostructured lipid carrier
|
AU2021335334A1
(en)
|
2020-09-04 |
2023-04-20 |
Access To Advanced Health Institute |
Genetically-adjuvanted rna vaccines
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
CN115927472A
(zh)
|
2021-07-05 |
2023-04-07 |
武汉纽福斯生物科技有限公司 |
一种抗vegf抗体体内表达系统的构建和应用
|
KR20240042489A
(ko)
|
2021-08-06 |
2024-04-02 |
우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 |
Nd4 돌연변이에 의해 야기되는 레베르 유전성 시신경병증을 치료하기 위한 조성물 및 방법
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之pd-l1結合多肽
|
TW202334196A
(zh)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1結合多肽
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|